Skip to main content
Year archive

SUPHA PHARMACHEM LIMITED — 2026 filings

All 16 regulatory filings released by SUPHA PHARMACHEM LIMITED (539561) in 2026, sourced directly from the official regulator.

16 Filings
2026 Period
2026 filings (16)
Filing Released Lang
Appointment of Resolution Professional in place of Interim Resolution Professional
Regulatory Filings
2026-05-12 English
Disclosure to take note of decisions taken in 1st COC meeting held on 14.04.2026
Regulatory Filings
2026-04-17 English
This disclosure is to place on record List of Creditors as required to be placed under Reg 13(2)(c) of IBBI CIRP Regulations
Regulatory Filings
2026-04-10 English
Update on CIRP Proceedings, Non-Cooperation by Directors (Power suspended) and Postponement of Board Meeting under Regulation 30 of SEBI (LODR) Regulation, 2015
Regulatory Filings
2026-04-02 English
Closure of Trading window
Regulatory Filings
2026-03-25 English
Intimation of receipt of Order from National Company Law Tribunal (NCLT)
Regulatory Filings
2026-03-21 English
Submission of Form A - PUBLIC ANNOUNCEMENT
Regulatory Filings
2026-03-20 English
Intimation for Admission of Co. under CIRP and appointment of IRP
Regulatory Filings
2026-03-19 English
Intimation of change in registered office of the company to office no. F81D, Express Zone Mall, A wing Next to Patel Vanika, W.E. Highway, Goregaon, (East), Mumbai - 400063, w.e.f. 17th ....
Regulatory Filings
2026-03-17 English
Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/03/2026 ,inter alia, to consider and approve To consider Un-Audited Financial ....
Regulatory Filings
2026-03-09 English
Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/03/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ...
Regulatory Filings
2026-02-25 English
Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/02/2026 ,inter alia, to consider and approve unaudited standalone and consolidated ...
Regulatory Filings
2026-02-17 English
Rescheduling on 25/02/2026
Regulatory Filings
2026-02-14 English
Demise of CS and Compliance Officer
Regulatory Filings
2026-02-14 English
Supha Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Un-Audited Financial Results/Statements
Regulatory Filings
2026-02-03 English
Submission of Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31.12.2025
Regulatory Filings
2026-01-20 English